104 Corporation (TPE:3130)

Achilles Therapeutics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	747.65	1,260	1,338	1,326	2,521	2,237
Short-Term Investments	2,269	1,837	1,562	1,522	-	-
Cash & Short-Term Investments	3,017	3,097	2,900	2,848	2,521	2,237
Cash Growth	4.15%	6.81%	1.81%	12.97%	12.72%	3.13%
Accounts Receivable	83.66	74.81	67.65	80.27	74.99	51.07
Other Receivables	14.42	11.15	11.94	10.08	9.25	9.33
Receivables	98.08	85.96	79.59	90.35	84.24	60.4
Prepaid Expenses	52.66	62.38	50.25	32.71	-	-
Other Current Assets	1.87	1.7	1.67	0.63	26.7	37.04
Total Current Assets	3,169	3,247	3,031	2,972	2,632	2,334
Property, Plant & Equipment	385.41	398.12	404.09	299.48	277.76	285.71
Long-Term Investments	186.02	25.96	32.48	4.91	4.43	4.56
Other Intangible Assets	31.28	34.29	12.71	0.36	1.02	1.55
Long-Term Deferred Tax Assets	9.18	9.18	11.13	15.09	9.15	8.64
Other Long-Term Assets	26.98	22.91	36.07	23.6	21.29	23.11
Total Assets	3,808	3,738	3,528	3,315	2,946	2,658
Accounts Payable	4.01	14.22	5.41	7.95	6.92	1.91
Accrued Expenses	49.38	45.83	42.79	38.2	36.46	30.21
Current Portion of Leases	42.44	42.33	42.64	33.85	31.6	32.89
Current Income Taxes Payable	88.68	61.65	57.6	60.94	42.96	44.95
Current Unearned Revenue	1,196	1,114	966.31	835.75	682.84	600.88
Other Current Liabilities	541.84	666.81	637.31	614.35	524.17	423.6
Total Current Liabilities	1,922	1,945	1,752	1,591	1,325	1,134
Long-Term Leases	94.85	107.02	104.69	57.86	36.45	44.73
Long-Term Deferred Tax Liabilities	0.07	0.07	0	-	-	-
Total Liabilities	2,017	2,052	1,870	1,662	1,370	1,192
Common Stock	331.91	331.91	331.91	331.91	331.91	331.91
Additional Paid-In Capital	397.57	397.57	397.57	397.57	397.57	397.57
Retained Earnings	1,064	957.68	933.19	927.32	849.26	735.95
Comprehensive Income & Other	-2.3	-1.86	-4.67	-3.87	-5.71	-5.34
Total Common Equity	1,791	1,685	1,658	1,653	1,573	1,460
Minority Interest	-	-	-	-	2.42	5.65
Shareholders' Equity	1,791	1,685	1,658	1,653	1,575	1,466
Total Liabilities & Equity	3,808	3,738	3,528	3,315	2,946	2,658
Total Debt	137.29	149.36	147.33	91.71	68.05	77.63
Net Cash (Debt)	2,879	2,948	2,752	2,756	2,453	2,159
Net Cash Growth	4.55%	7.11%	-0.15%	12.37%	13.62%	3.18%
Net Cash Per Share	86.05	88.10	82.25	82.39	73.38	64.64
Filing Date Shares Outstanding	33.19	33.19	33.19	33.19	33.19	33.19
Total Common Shares Outstanding	33.19	33.19	33.19	33.19	33.19	33.19
Working Capital	1,247	1,302	1,279	1,381	1,307	1,200
Book Value Per Share	53.96	50.78	49.95	49.80	47.39	43.99
Tangible Book Value	1,760	1,651	1,645	1,653	1,572	1,459
Tangible Book Value Per Share	53.01	49.74	49.57	49.79	47.36	43.95
Land	103.56	103.56	103.56	103.56	103.56	103.56
Buildings	80.25	80.25	80.58	76.97	76.97	76.78
Machinery	345.27	344.64	408.63	409.91	427.99	398.04
Leasehold Improvements	75.09	70.34	67.58	57.05	53.29	54.13

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.